Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT05201859 2022-05-06

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Phase 2 Unknown

150 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04510818 2020-08-14

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Phase 1 Unknown

20 enrolled

Head & Neck

Head and Neck Neoplasms

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Phase 2 Unknown

129 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02958111 2019-06-12

CAN

Phase 3 Unknown

406 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03678649 2018-09-19

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Phase 2 Unknown

180 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02786641 2016-06-01

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

235 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02621970 2015-12-04

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Phase 3 Unknown

534 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

EP-STAR

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

GEN602

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

CAN

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma